You can buy or sell TNXP and other stocks, options, ETFs, and crypto commission-free!
Tonix Pharmaceuticals Holding Corp. Common Stock, also called Tonix Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Read More It focuses on delivering a safe and effective long-term treatment for posttraumatic stress disorder. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Nov 8, Pre-Market